Lexicon Pharmaceuticals, Inc. 37.3% Potential Upside Now Implied ... - DirectorsTalk Interviews

Thorold News
Lexicon Pharmaceuticals, Inc. 37.3% Potential Upside Now Implied ...
DirectorsTalk Interviews
Lexicon Pharmaceuticals, Inc. with TICKER NASDAQ:LXRX had its stock rating noted as 'Initiated' with the recommendation being set at 'BUY' on Friday by ana.
Today's Rating Alert: H.C. Wainwright Initiates Buy Rating, $26.00 ...Thorold News
HC Wainwright Initiates Coverage on Zynerba Pharmaceuticals Inc. (ZYNE)Community Financial News
Lexicon Pharmaceuticals Inc. (LXRX) Receives New Coverag